These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 33175263)

  • 1. Use of 55 PET radiotracers under approval of a Radioactive Drug Research Committee (RDRC).
    Jackson IM; Lee SJ; Sowa AR; Rodnick ME; Bruton L; Clark M; Preshlock S; Rothley J; Rogers VE; Botti LE; Henderson BD; Hockley BG; Torres J; Raffel DM; Brooks AF; Frey KA; Kilbourn MR; Koeppe RA; Shao X; Scott PJH
    EJNMMI Radiopharm Chem; 2020 Nov; 5(1):24. PubMed ID: 33175263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The radioactive drug research committee: Background and retrospective study of reported research data (1975-2004).
    Suleiman OH; Fejka R; Houn F; Walsh M
    J Nucl Med; 2006 Jul; 47(7):1220-6. PubMed ID: 16818959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rational regulatory approach for positron emission tomography imaging probes: from "first in man" to NDA approval and reimbursement.
    Barrio JR; Marcus CS; Hung JC; Keppler JS
    Mol Imaging Biol; 2004; 6(6):361-7. PubMed ID: 15564146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food and Drug Administration requirements for testing and approval of new radiopharmaceuticals.
    Harapanhalli RS
    Semin Nucl Med; 2010 Sep; 40(5):364-84. PubMed ID: 20674596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bringing New PET drugs to clinical practice - a regulatory perspective.
    Hung JC
    Theranostics; 2013 Nov; 3(11):885-93. PubMed ID: 24312157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A philosophy for CNS radiotracer design.
    Van de Bittner GC; Ricq EL; Hooker JM
    Acc Chem Res; 2014 Oct; 47(10):3127-34. PubMed ID: 25272291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Planning Implications Related to Sterilization-Sensitive Science Investigations Associated with Mars Sample Return (MSR).
    Velbel MA; Cockell CS; Glavin DP; Marty B; Regberg AB; Smith AL; Tosca NJ; Wadhwa M; Kminek G; Meyer MA; Beaty DW; Carrier BL; Haltigin T; Hays LE; Agee CB; Busemann H; Cavalazzi B; Debaille V; Grady MM; Hauber E; Hutzler A; McCubbin FM; Pratt LM; Smith CL; Summons RE; Swindle TD; Tait KT; Udry A; Usui T; Westall F; Zorzano MP
    Astrobiology; 2022 Jun; 22(S1):S112-S164. PubMed ID: 34904892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[
    Katzenellenbogen JA
    Nucl Med Biol; 2021 Jan; 92():24-37. PubMed ID: 32229068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
    Gulyás B; Halldin C
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):173-90. PubMed ID: 22617239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical dosimetry models and the prediction of clinical doses of novel positron emission tomography radiotracers.
    Garrow AA; Andrews JPM; Gonzalez ZN; Corral CA; Portal C; Morgan TEF; Walton T; Wilson I; Newby DE; Lucatelli C; Tavares AAS
    Sci Rep; 2020 Sep; 10(1):15985. PubMed ID: 32994530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon-11 patents (2012-2022): synthetic methodologies and novel radiotracers for PET imaging.
    Nerella SG; Singh P; Tulja S
    Expert Opin Ther Pat; 2022 Jul; 32(7):817-831. PubMed ID: 35451896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges for Developing PET Tracers: Isotopes, Chemistry, and Regulatory Aspects.
    Mach RH; Schwarz SW
    PET Clin; 2010 Apr; 5(2):131-53. PubMed ID: 27157669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying novel radiotracers for PET imaging of the brain: application of LC-MS/MS to tracer identification.
    Barth V; Need A
    ACS Chem Neurosci; 2014 Dec; 5(12):1148-53. PubMed ID: 24828747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Half-Life
    Cornelis FH; Durack JC; Pandit-Taskar N; Ulaner GA; Lewis JS; Morris MJ; Solomon SB
    J Nucl Med; 2018 Mar; 59(3):399-402. PubMed ID: 28818992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET).
    Gomes PMO; Silva AMS; Silva VLM
    Molecules; 2020 Apr; 25(7):. PubMed ID: 32283680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PET radiotracers: crossing the blood-brain barrier and surviving metabolism.
    Pike VW
    Trends Pharmacol Sci; 2009 Aug; 30(8):431-40. PubMed ID: 19616318
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.